Atelocollagen supports three-dimensional culture of human induced pluripotent stem cells

IF 4.6 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL
{"title":"Atelocollagen supports three-dimensional culture of human induced pluripotent stem cells","authors":"","doi":"10.1016/j.omtm.2024.101302","DOIUrl":null,"url":null,"abstract":"<p>As autologous iPSC therapy requires a custom-made small-lot cell production line, the cell production method differs significantly from the existing processes for producing allogeneic iPSC stocks for clinical use. Specifically, mass culture to produce stock is no longer necessary; instead, a series of operations from iPSC production to induction of differentiation of therapeutic cells must be performed continuously. A 3D culture method using small, closed-cell manufacturing devices is suitable for autologous iPSC therapy. Use of such devices avoids the need to handle many patient-derived specimens in a single clean room; handling of cell cultures in an open system in a cell processing facility increases the risk of infection. In this study, atelocollagen beads were evaluated as a three-dimensional biomaterial to assist 3D culture in the establishment, expansion culture, and induced differentiation of iPSCs. It was found that iPSCs can be handled in a closed-cell device with the same ease as use of 2D culture when Laminin-511 is added to the medium. In conclusion, atelocollagen beads enable 3D culture of iPSCs, and the quality of the obtained cells is at the same level as those derived from 2D culture.</p>","PeriodicalId":54333,"journal":{"name":"Molecular Therapy-Methods & Clinical Development","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Therapy-Methods & Clinical Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.omtm.2024.101302","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

As autologous iPSC therapy requires a custom-made small-lot cell production line, the cell production method differs significantly from the existing processes for producing allogeneic iPSC stocks for clinical use. Specifically, mass culture to produce stock is no longer necessary; instead, a series of operations from iPSC production to induction of differentiation of therapeutic cells must be performed continuously. A 3D culture method using small, closed-cell manufacturing devices is suitable for autologous iPSC therapy. Use of such devices avoids the need to handle many patient-derived specimens in a single clean room; handling of cell cultures in an open system in a cell processing facility increases the risk of infection. In this study, atelocollagen beads were evaluated as a three-dimensional biomaterial to assist 3D culture in the establishment, expansion culture, and induced differentiation of iPSCs. It was found that iPSCs can be handled in a closed-cell device with the same ease as use of 2D culture when Laminin-511 is added to the medium. In conclusion, atelocollagen beads enable 3D culture of iPSCs, and the quality of the obtained cells is at the same level as those derived from 2D culture.

Abstract Image

Atelocollagen 支持人类诱导多能干细胞的三维培养
由于自体 iPSC 疗法需要定制的小批量细胞生产线,因此细胞生产方法与现有的用于临床的异体 iPSC 储存生产工艺有很大不同。具体来说,不再需要大规模培养来生产储备细胞,而是必须连续进行从 iPSC 生产到诱导治疗细胞分化的一系列操作。使用小型封闭细胞制造装置的三维培养方法适用于自体 iPSC 治疗。使用这种装置可避免在一个洁净室中处理许多患者来源的标本;在细胞处理设施的开放系统中处理细胞培养物会增加感染风险。在这项研究中,对阿特劳胶原蛋白珠作为一种三维生物材料进行了评估,以协助三维培养iPSCs的建立、扩增培养和诱导分化。研究发现,在培养基中添加 Laminin-511 后,iPSCs 可在闭孔装置中进行处理,与使用二维培养一样方便。总之,atelocollagen 珠可以实现 iPSCs 的三维培养,而且获得的细胞质量与二维培养的细胞质量相同。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Molecular Therapy-Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development Biochemistry, Genetics and Molecular Biology-Molecular Biology
CiteScore
9.90
自引率
4.30%
发文量
163
审稿时长
12 weeks
期刊介绍: The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella. Topics of particular interest within the journal''s scope include: Gene vector engineering and production, Methods for targeted genome editing and engineering, Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells, Methods for gene and cell vector delivery, Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine, Analysis of gene and cell vector biodistribution and tracking, Pharmacology/toxicology studies of new and next-generation vectors, Methods for cell isolation, engineering, culture, expansion, and transplantation, Cell processing, storage, and banking for therapeutic application, Preclinical and QC/QA assay development, Translational and clinical scale-up and Good Manufacturing procedures and process development, Clinical protocol development, Computational and bioinformatic methods for analysis, modeling, or visualization of biological data, Negotiating the regulatory approval process and obtaining such approval for clinical trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信